Cancer Metabolomics Approaches

Metabolomics cancer research is being used to discover diagnostic cancer biomarkers in the clinic and in a research institute, to a better understand its complex heterogeneous nature, to discover pathways which involved in cancer that could be used for new targets and to monitor metabolic biomarkers during therapeutic intervention. These metabolomics approaches may also provide evidence to personalized cancer treatments by providing useful information to the clinician about the cancer patient’s response to medical interventions. The ultimate aims of most metabolomics cancer studies are to discover cancer-specific diagnostic, prognostic or predictive biomarkers for a patient. Untargeted metabolomics is an important and excellent tool for probing cancer-altered biochemical pathways.



 


    Related Conference of Cancer Metabolomics Approaches

    June 13-14, 2024

    30th Asia Pacific Biotechnology Congress

    Dubai, UAE
    July 11-12, 2024

    6th International Conference on Biochemistry

    Paris, France
    September 25-26, 2024

    20th World Congress on Structural Biology

    Paris, France
    December 12-13, 2024

    15th World Congress on Cell & Tissue Science

    Rome, Italy

    Cancer Metabolomics Approaches Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in